NCT06424704

Brief Summary

This study is planned to reveal the microbiological agents and drug sensitivities to these agents in patients diagnosed with chronic suppurative otitis media who complain of ear discharge.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2024

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 16, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 22, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

May 22, 2024

Status Verified

May 1, 2024

Enrollment Period

2 years

First QC Date

May 16, 2024

Last Update Submit

May 16, 2024

Conditions

Keywords

Chronic suppurative otitis mediaCholesteatomaEar discharge

Outcome Measures

Primary Outcomes (1)

  • Microbiology of chronic suppurative otitis media

    Microbiology in patients diagnosed with chronic suppurative otitis media with and without cholesteatoma

    2024-2026 (24 months)

Secondary Outcomes (1)

  • Antibiotic susceptibility in chronic suppurative otitis media

    2024-2026 (24 months)

Study Arms (2)

Chronic suppurative otitis media with cholesteatoma (Chole)

Patients who applied to Selçuk University Faculty of Medicine Hospital, Department of Ear, Nose and Throat Diseases \& Head and Neck Surgery with complaints of ear discharge and were diagnosed with chronic suppurative otitis media with cholesteatoma were included in the study.

Diagnostic Test: Microbiological culture

Chronic suppurative otitis media without cholesteatoma (CSOM)

The study included patients who applied to Selçuk University Faculty of Medicine Hospital, Department of Ear, Nose and Throat Diseases \& Head and Neck Surgery, with complaints of ear discharge and were diagnosed with chronic suppurative otitis media without cholesteatoma.

Diagnostic Test: Microbiological culture

Interventions

Samples taken from chronic suppurative otitis media patients in the Medical Microbiology Laboratory of Selçuk University Faculty of Medicine will be planted in 5% sheep blood Columbia agar, eosin methylene blue agar and saboraud dextrose agar, and the media will be incubated at 37oC for 24-48 hours. Growing bacteria and fungi were examined using traditional methods \[Gram staining, catalase test, coagulase test, bacitracin disk, PYR test (L-pyrrolidonyl-β-naphthylamide), oxidase test, IMViC test, lactophenol cotton blue, etc.\] and VITEK 2 (bioMerieux, France).

Also known as: Antibiotic susceptibility tests will be performed with the Kirby Bauer disc diffusion test and VITEK2 automated system (bioMerieux, France).
Chronic suppurative otitis media with cholesteatoma (Chole)Chronic suppurative otitis media without cholesteatoma (CSOM)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study will include patients who applied to Selçuk University Faculty of Medicine Hospital, Department of Ear, Nose and Throat Diseases \& Head and Neck Surgery, with complaints of ear discharge and were diagnosed with chronic suppurative otitis media.

You may qualify if:

  • Patients diagnosed with chronic suppurative otitis media
  • Patients over 18 years of age

You may not qualify if:

  • Chronic nonsuppurative otitis media patients
  • Patients diagnosed with external ear canal/middle ear malignancy
  • Patients who take immunosuppressive drugs
  • Immunosuppressive patients
  • Patients who used antibiotics (topical-systemic) in the last week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bulent ULUSOY

Konya, Selcuklu, 42100, Turkey (Türkiye)

Location

Selcuk University

Konya, Selcuklu, 42100, Turkey (Türkiye)

Location

Related Publications (2)

  • Khairkar M, Deshmukh P, Maity H, Deotale V. Chronic Suppurative Otitis Media: A Comprehensive Review of Epidemiology, Pathogenesis, Microbiology, and Complications. Cureus. 2023 Aug 18;15(8):e43729. doi: 10.7759/cureus.43729. eCollection 2023 Aug.

    PMID: 37727177BACKGROUND
  • Verhoeff M, van der Veen EL, Rovers MM, Sanders EA, Schilder AG. Chronic suppurative otitis media: a review. Int J Pediatr Otorhinolaryngol. 2006 Jan;70(1):1-12. doi: 10.1016/j.ijporl.2005.08.021. Epub 2005 Sep 27.

    PMID: 16198004BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Culture samples taken from the ears of patients with chronic suppurative otitis media with cholesteatoma and chronic suppurative otitis media without cholesteatom.

MeSH Terms

Conditions

Otitis MediaCholesteatomaCommunicable Diseases

Condition Hierarchy (Ancestors)

OtitisEar DiseasesOtorhinolaryngologic DiseasesKeratosisSkin DiseasesSkin and Connective Tissue DiseasesInfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Bulent Ulusoy, MD

    Selcuk University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Burcu Tuğba Aldora

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Selcuk University Faculty of Medicine

Study Record Dates

First Submitted

May 16, 2024

First Posted

May 22, 2024

Study Start

May 15, 2024

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

May 22, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations